story of the week
Major Adverse Cardiovascular and Limb Events in People With Diabetes Treated With GLP-1 Receptor Agonists vs SGLT2 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors
Diabetologia 2022 Dec 01;65(12)2032-2043, DS Lin, AL Yu, HY Lo, CW Lien, JK Lee, WJ ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.